Mace Rothenberg, M.D.

Mace Rothenberg, M.D.

DirectoratTango Therapeutics· In proxies 2023–2025

Mace Rothenberg, M.D. sits on 6 public boards.

Boards2

  • Surrozen, Inc./DEDirector · 4 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
  • Tango TherapeuticsDirector · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Tango TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +205%
  2. Surrozen, Inc./DEPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Chiara BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  4. Aulos BiosciencePublic company
    • Director? – PresentNo stock prices for these years
  5. Surrozen, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?